biostudies-literatureUnknown37(11)Shih EPhilanthropic gift from Satish and Yasmin Gupta to Baylor Scott & White The Heart Hospital, Plano<h4>Background</h4>Although several studies have characterized the risk of coinfection in COVID pneumonia, the risk of the bloodstream and respiratory coinfection in patients with COVID-19 pneumonia on extracorporeal membrane oxygenation (ECMO) supports severe acute respiratory distress syndrome (ARDS) is poorly understood.<h4>Methods</h4>This is a retrospective analysis of patients with COVID-19 ARDS on ECMO at a single center between January 2020 and December 2021. Patient characteristics and clinical outcomes were compared.<h4>Results</h4>Of 44 patients placed on ECMO support for COVID-19 ARDS, 30 (68.2%) patients developed a coinfection, and 14 (31.8%) patients did not. Most patients underwent venovenous ECMO (98%; 43/44) cannulation in the right internal jugular vein (98%; 43/44). PatJournal of cardiac surgery3609-3618https://www.ebi.ac.uk/biostudies/studies/S-EPMC9538542biostudies-literatureBloodstream and respiratory coinfections in patients with COVID-19 on ECMO.PMC9538542George TJShih EMeyers DPBanwait JKMeidan TGSheasby JSquiers JJKussman HMMichael DiMaio JfalseBloodstream and respiratory coinfections in patients with COVID-19 on ECMO.<h4>Background</h4>Although several studies have characterized the risk of coinfection in COVID pneumonia, the risk of the bloodstream and respiratory coinfection in patients with COVID-19 pneumonia on extracorporeal membrane oxygenation (ECMO) supports severe acute respiratory distress syndrome (ARDS) is poorly understood.<h4>Methods</h4>This is a retrospective analysis of patients with COVID-19 ARDS on ECMO at a single center between January 2020 and December 2021. Patient characteristics and clinical outcomes were compared.<h4>Results</h4>Of 44 patients placed on ECMO support for COVID-19 ARDS, 30 (68.2%) patients developed a coinfection, and 14 (31.8%) patients did not. Most patients underwent venovenous ECMO (98%; 43/44) cannulation in the right internal jugular vein (98%; 43/44). Pat2022-01-01T00:00:00Z2022 Nov2025-04-05T11:38:21.687Z2025-04-05T11:38:21.687ZS-EPMC95385423607313610.1111/jocs.16909